Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Türkiye: 48-Month Data, BOSPHORUS-DME Study Group Report No. 1

[LANGUAGE=”English”]ObjectivesThis study aimed to evaluate the 48-month visual and anatomical outcomes, as well as the number of clinic visits and intravitreal injections, in patients treated with three consecutive loading doses of intravitreal anti-vascular endothelial growth factor (anti-VEGF) the...

Full description

Saved in:

Bibliographic Details
Published in:	Turk oftalmoloji gazetesi 2026-02, Vol.56 (1), p.31
Main Authors:	Özal, Ece, Özkaya, Abdullah, Arıcı, Murat, Korkmaz, Anıl, Ermiş, Serhat, Hayat, Şerife Çiloğlu, Karapapak, Murat, Sadık Altan Özal, Çakır, Akın, Karataş, Gamze, Yıldız, Dilan, Erdoğan, Mehmet, Koçak, İbrahim, Sayın, Nihat, Veysel Levent Karabaş, Ecem Önder Tokuç, Semra Tiryaki Demir, Karataş, Mehmet Egemen, Uçak, Turgay, Öztürk, Mine, Demirayak, Bengi, İsmail Umut Onur, Hepokur, Mustafa
Format:	Article
Language:	Turkish
Subjects:	Diabetes Diabetic retinopathy Edema Medical referrals Ophthalmology Patients Reimbursement Variables Variance analysis Vascular endothelial growth factor
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!